Search research articles
Contact Us
Filters
Showing results (91-100 of 277) with videos related to
Page
of 28
Sort By:
Pathology Oncology Research : POR
|
June 23, 2019
The Relationship Between Tumor-Infiltrating Lymphocytes, PD-L1 Expression, Driver Mutations and Clinical Outcome Parameters in Non-Small Cell Lung Cancer Adenocarcinoma in Patients with a Limited to no Smoking History
Sacha Mignon, Karen Willard-Gallo, Gert Van den Eynden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2022
Selecting patients with HER2-low breast cancer: Getting out of the tangle
Ximena Baez-Navarro, Roberto Salgado, Carsten Denkert, et al.
Journal of Neuroimmunology
|
June 12, 2014
Reciprocal interaction between the suprachiasmatic nucleus and the immune system tunes down the inflammatory response to lipopolysaccharide
Natalí N Guerrero-Vargas, Roberto Salgado-Delgado, María Del Carmen Basualdo, et al.
Eclinicalmedicine
|
December 5, 2024
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, et al.
Journal of Pathology Informatics
|
December 25, 2024
Prioritizing cases from a multi-institutional cohort for a dataset of pathologist annotations
Victor Garcia, Emma Gardecki, Stephanie Jou, et al.
The Journal of Endocrinology
|
August 31, 2017
Food in synchrony with melatonin and corticosterone relieves constant light disturbed metabolism
Adrián Báez-Ruiz, Natalí N Guerrero-Vargas, Fernando Cázarez-Márquez, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 27, 2025
PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial
Martin Manley, Guilherme Nader-Marta, Ayça Arcay Ozturk, et al.
Virchows Archiv : an International Journal of Pathology
|
April 20, 2026
Level of estrogen receptor expression, histological grade, and computationally assessed stromal TILs on pre-treatment biopsies predict pathological complete response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer
Dusan Rasic, Elisabeth Ida Specht Stovgaard, Anne Marie Bak Jylling, et al.
The Lancet. Oncology
|
December 15, 2016
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
Stephen J Luen, Roberto Salgado, Stephen Fox, et al.
NPJ Breast Cancer
|
July 2, 2026
Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer
William S O Symmans, Kevin Tran, Chunxiao Fu, et al.
Page
of 28
Search research articles
Search
Showing results (91-100 of 277) with videos related to
Sort By:
Page
of 28
Pathology Oncology Research : POR
|
June 23, 2019
The Relationship Between Tumor-Infiltrating Lymphocytes, PD-L1 Expression, Driver Mutations and Clinical Outcome Parameters in Non-Small Cell Lung Cancer Adenocarcinoma in Patients with a Limited to no Smoking History
Sacha Mignon, Karen Willard-Gallo, Gert Van den Eynden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2022
Selecting patients with HER2-low breast cancer: Getting out of the tangle
Ximena Baez-Navarro, Roberto Salgado, Carsten Denkert, et al.
Journal of Neuroimmunology
|
June 12, 2014
Reciprocal interaction between the suprachiasmatic nucleus and the immune system tunes down the inflammatory response to lipopolysaccharide
Natalí N Guerrero-Vargas, Roberto Salgado-Delgado, María Del Carmen Basualdo, et al.
Eclinicalmedicine
|
December 5, 2024
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, et al.
Journal of Pathology Informatics
|
December 25, 2024
Prioritizing cases from a multi-institutional cohort for a dataset of pathologist annotations
Victor Garcia, Emma Gardecki, Stephanie Jou, et al.
The Journal of Endocrinology
|
August 31, 2017
Food in synchrony with melatonin and corticosterone relieves constant light disturbed metabolism
Adrián Báez-Ruiz, Natalí N Guerrero-Vargas, Fernando Cázarez-Márquez, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 27, 2025
PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial
Martin Manley, Guilherme Nader-Marta, Ayça Arcay Ozturk, et al.
Virchows Archiv : an International Journal of Pathology
|
April 20, 2026
Level of estrogen receptor expression, histological grade, and computationally assessed stromal TILs on pre-treatment biopsies predict pathological complete response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer
Dusan Rasic, Elisabeth Ida Specht Stovgaard, Anne Marie Bak Jylling, et al.
The Lancet. Oncology
|
December 15, 2016
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
Stephen J Luen, Roberto Salgado, Stephen Fox, et al.
NPJ Breast Cancer
|
July 2, 2026
Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer
William S O Symmans, Kevin Tran, Chunxiao Fu, et al.
Page
of 28